Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CD5L antibody (N-Term)

This anti-CD5L antibody is a Rabbit Polyclonal antibody detecting CD5L in WB and ELISA. Suitable for Human.
Catalog No. ABIN2227977

Quick Overview for CD5L antibody (N-Term) (ABIN2227977)

Target

See all CD5L Antibodies
CD5L (CD5 Molecule-Like (CD5L))

Reactivity

  • 41
  • 35
  • 26
Human

Host

  • 72
  • 6
  • 1
Rabbit

Clonality

  • 71
  • 5
  • 2
Polyclonal

Conjugate

  • 34
  • 15
  • 8
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CD5L antibody is un-conjugated

Application

  • 53
  • 26
  • 21
  • 15
  • 13
  • 13
  • 12
  • 8
  • 7
  • 4
  • 3
  • 3
  • 2
  • 1
Western Blotting (WB), ELISA
  • Binding Specificity

    • 15
    • 8
    • 4
    • 4
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    AA 64-93, N-Term

    Cross-Reactivity

    Human

    Cross-Reactivity (Details)

    Calculated cross reactivity: Hu

    Characteristics

    CD5L, NT (CD5L, API6, CD5 antigen-like, CT-2, IgM-associated peptide, SP-alpha)

    Purification

    Purified by Protein A affinity chromatography.

    Immunogen

    CD5L antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 64-93 amino acids from the N-terminal region of human CD5L.

    Isotype

    IgG
  • Application Notes

    Optimal working conditions should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C

    Storage Comment

    -20°C
  • Target

    CD5L (CD5 Molecule-Like (CD5L))

    Alternative Name

    CD5L

    NCBI Accession

    NP_005885

    UniProt

    O43866
You are here:
Chat with us!